The latest from BioStock
» Alzinova's CEO: "This strengthens our negotiating position towards potential partners"
» Elicera nears study start of its first clinical CAR T-cell trial CARMA
» Prolights Diagnostics CEO: “We continue to deliver what we promise”
» Kjell Stenberg returns as CEO of Cyxone
» Prolight Diagnostics strengthens the board with experienced business developer
Read BioStock's weekly newsletter for v.21 here.
The latest news of the day
announces that a single treatment with ProTrans shows effect on type-1 diabetes for over 5 years. Read more.
BergenBio announces clinical collaboration with UT Health San Antonio and Sobi. Read moreThe company also informs about a reverse split. Read more.
Prolight has obtained subscription commitments for the exercise of warrants of series TO6 from, among others, members of the board and management of approximately SEK 1,0 million. Read more.
Sedana Medical completes patient recruitment for the company's clinical program in the US. Read more.
Episurf Medical additional distribution agreements are entered into with exclusive distributors for DePuy Synthes, the orthopedic part of Johnson & JohnsonGroup. Read more.
SciBase launches eBarrier Score, the first AI-powered skin barrier assessment analysis tool for research and cosmetic testing. Read more.
Qlucore announces that the Academic Hospital selects AI-based Qlucore Insights for its investment in precision diagnostics. Read more.
Calliditas Therapeutics has presented data at the 61st Congress of the European Renal Association. Read more.
Carbiotix announces strategic refocusing and reorganization of personnel. Read more.
Ziccum begins cooperation with Dagens Industri for Investor Relations programs. Read more.
Today, May 29th, the subscription period begins in Lipidors rights issue. Read moreThe company invites you to an investor presentation. Read more.
Micropos Medicals CEO sums up impressions after ESTRO 2024. Read more.
CS Medica has received a loan of DKK 2 million to support its short- and medium-term financing needs. Read more.
Asarina Pharma announces new date for publication of the annual report for 2023. Read more.
Circio Holding announces rights issue that secures cash for twelve months. Read moreThe company informs about the terms and conditions thereof. Read more.
DBP International announces a European patent for the technology platform BeloGal. Read more.
Attana invites existing and new shareholders to an information meeting about future plans and financing. Read more.
This morning's price development
Index: OMXS30 -0,43% Healthcare -0,73%
| Winner | Förlorare |
| Klaria Pharma +30,86% | Circio Holding -49,02% |
| Amniotic +26,67% | NextCell Pharma -35,26% |
| DPB International +14,29% | CLS -20,93% |
| QLife +9,09% | Eurocine Vaccines -16,14% |
| Medivir +8,93% | Lipids -15,18% |